ADVANCED CHOLANGIOCARCINOMA
Clinical trials for ADVANCED CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New targeted drug shows promise for rare bile duct cancer
Disease control Recruiting nowThis Phase 2 trial is testing two doses (20 mg and 16 mg) of the oral drug futibatinib in 120 people with advanced bile duct cancer that has specific FGFR2 gene changes. Participants must have already tried standard chemotherapy. The study aims to see which dose works better at s…
Matched conditions: ADVANCED CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug AU409 enters first human trial for tough liver cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called AU409 in 36 people with advanced liver cancers or solid tumors that have spread to the liver. The main goals are to find the safest dose and check for side effects. Researchers will also look for signs that the drug might shrink tumo…
Matched conditions: ADVANCED CHOLANGIOCARCINOMA
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo aims to stall bile duct cancer after chemo
Disease control Recruiting nowThis phase 2 trial is testing whether combining two drugs—durvalumab (an immunotherapy) and olaparib (a targeted therapy)—can help keep advanced bile duct cancer from growing after initial chemotherapy. The study will enroll 40 adults with locally advanced or metastatic cholangio…
Matched conditions: ADVANCED CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Australasian Gastro-Intestinal Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug cocktail targets rare bile duct cancer
Disease control Recruiting nowThis study tests whether combining three drugs—pemigatinib, atezolizumab, and bevacizumab—can help control advanced bile duct cancer that has a specific genetic change (FGFR2 fusion). About 25 adults whose cancer has not responded to other treatments will take part. The main goal…
Matched conditions: ADVANCED CHOLANGIOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Cancer care at home: a game changer for patients?
Symptom relief Recruiting nowThis study compares giving cancer treatment at home versus in the clinic for people with advanced cancers. The goal is to see if home treatment reduces stress, financial burden, and improves overall experience. About 220 participants will be randomly assigned to receive their reg…
Matched conditions: ADVANCED CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC